These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 7171318
1. [Study of IgG antibody in Japanese cedar pollenosis patients. I. Measurement of IgG antibody to Japanese cedar pollen antigens by radioimmunoassay]. Ito Y. Arerugi; 1982 Dec; 31(12):1231-8. PubMed ID: 7171318 [No Abstract] [Full Text] [Related]
2. [IgG antibody in Japanese cedar pollenosis patients. II. Effects of desensitization and seasonal exposure to cedar pollen on IgG and IgE antibodies in the serum and nasal secretions]. Ito Y. Arerugi; 1983 Sep; 32(9):985-95. PubMed ID: 6667129 [No Abstract] [Full Text] [Related]
3. Blocking antibody is generated in allergic rhinitis patients during specific immunotherapy using standardized Japanese cedar pollen extract. Kawakami A, Koketsu R, Suzukawa M, Nagao M, Hiraguchi Y, Tokuda R, Fujisawa T, Nagase H, Ohta K, Yamamoto K, Yamaguchi M. Int Arch Allergy Immunol; 2008 Sep; 146 Suppl 1():54-60. PubMed ID: 18504408 [Abstract] [Full Text] [Related]
4. [Characteristics of pollen scattering from male sugi flowers in relation to occurring of symptoms in Japanese cedar pollenosis patients]. Taira H, Shouji T, Teranishi H, Kenda Y, Keyaki Y. Arerugi; 1995 Apr; 44(4):467-73. PubMed ID: 7598640 [Abstract] [Full Text] [Related]
5. [Japanese cedar pollinosis in children in our allergy clinic]. Masuda S, Takeuchi K, Yuta A, Okawa C, Ukai K, Sakakura Y. Arerugi; 1998 Nov; 47(11):1182-9. PubMed ID: 9893335 [Abstract] [Full Text] [Related]
6. Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy. Ito H, Nishimura J, Suzuki M, Mamiya S, Sato K, Takagi I, Baba S. Ann Allergy Asthma Immunol; 1995 Apr; 74(4):299-303. PubMed ID: 7719888 [Abstract] [Full Text] [Related]
7. Seasonal increase in specific IgE in serum induced by natural Japanese cedar pollen exposure in asymptomatic and symptomatic sensitized individuals. Kakinoki Y, Ohashi Y, Kato A, Tanaka A, Washio Y, Yamada K, Masamoto T, Nasako Y, Nakai Y, Nakai Y. Acta Otolaryngol Suppl; 1998 Apr; 538():152-5. PubMed ID: 9879415 [Abstract] [Full Text] [Related]
8. Clinical evaluation of lumiward immunoassay system for detection of specific IgE associated with allergic rhinitis. Yamada K, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Hayashi M, Kishimoto K, Nakai Y. Acta Otolaryngol Suppl; 1998 Apr; 538():169-77. PubMed ID: 9879417 [Abstract] [Full Text] [Related]
9. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated. Ogino S, Nagakura T, Okubo K, Sato N, Takahashi M, Ishikawa T. Int Arch Allergy Immunol; 2009 Apr; 149(3):239-45. PubMed ID: 19218816 [Abstract] [Full Text] [Related]
10. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens. Nakai Y, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Masamoto T, Yamada K, Nakai Y, Ohmoto Y. Acta Otolaryngol Suppl; 1998 Apr; 538():143-51. PubMed ID: 9879414 [Abstract] [Full Text] [Related]
11. Evaluation of release fluoroimmunoassay (RFIA) for the determination of specific IgE antibody to Japanese cedar pollinosis. Nakazawa T, Sato K, Tsuchiya J. Ann Allergy; 1988 Sep; 61(3):214-5. PubMed ID: 3415053 [Abstract] [Full Text] [Related]
12. [Sensitization and onset of Japanese cedar pollinosis in children]. Mori A. Arerugi; 1995 Jan; 44(1):7-15. PubMed ID: 7702455 [Abstract] [Full Text] [Related]
14. [Clinical characterization of allergic patients sensitized to Chamaecyparis obtusa--using AlaSTAT system]. Okano M, Nishioka K, Nagano T, Ohta N, Masuda Y. Arerugi; 1994 Sep; 43(9):1179-84. PubMed ID: 7802602 [Abstract] [Full Text] [Related]
15. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study. Horiguchi S, Tanaka Y, Uchida T, Chazono H, Ookawa T, Sakurai D, Okamoto Y. Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160 [Abstract] [Full Text] [Related]
16. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination. Ito Y, Takahashi Y, Fujita T, Fukuyama S. Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139 [Abstract] [Full Text] [Related]
17. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T. Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178 [Abstract] [Full Text] [Related]
18. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis. Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K. J Immunol; 1998 Jul 01; 161(1):448-57. PubMed ID: 9647255 [Abstract] [Full Text] [Related]
19. [Clinical and immunological analysis of Birch pollenosis]. Takagi S. Hokkaido Igaku Zasshi; 1994 Nov 01; 69(6):1409-26. PubMed ID: 7705751 [Abstract] [Full Text] [Related]